Skip to content

Observation of the sedative effect of remimazolam combined with sufentanil intravenous anesthesia in painless gastrointestinal endoscopy in patients of different ages

Observation of the sedative effect of remimazolam combined with sufentanil intravenous anesthesia in painless gastrointestinal endoscopy in patients of different ages

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400093257
Enrollment
Unknown
Registered
2024-11-29
Start date
2024-12-01
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Painless gastrointestinal endoscopy

Interventions

Youth Group (18~44 years old):None
Middle-aged group (45~59 years old):None
Senior Group (60~79 years old):None
Elderly Group (= 80 years old):None

Sponsors

People's Hospital of Ningxia Hui Autonomous Region
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.ASA?~? 2. Age = 18 3. BMI 18~28 kg/m2. 4. Painless gastroscopy or gastrointestinal endoscopy

Exclusion criteria

Exclusion criteria: 1.Complex endoscopic techniques are required 2.Difficulty in airway management (modified Marhalanobis score III.-IV.) 3.Uncontrolled hypertension [SBP=160 mmHg and/or DBP=100 mmHg] 4.Allergy to the drugs involved in the study, pregnancy or lactation, severe systemic illness (e.g., asthma, sleep apnea syndrome, psychiatric disorders, etc.).

Design outcomes

Primary

MeasureTime frame
Sedation success rate;

Secondary

MeasureTime frame
Onset of sedation;Number of remedial sedations;Additional sedations;Incidence of motor reactions;Incidence of choking;Incidence of hiccups;Incidence of hypotension;Incidence of bradycardia;Incidence of hypoxemia;Incidence of nausea;Incidence of vomiting;Incidence of dizziness after waking up;

Countries

China

Contacts

Public ContactWang Ting

People's Hospital of Ningxia Hui Autonomous Region

804637498@qq.com+86 130 0796 1575

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026